title: Reply to 'Concern on quality-of-life analysis in the OPTIMAL study' by Couraud et al.
authors.forename: C
authors.initials: C
authors.lastname: Zhou
authors.forename: Y-L
authors.initials: YL
authors.lastname: Wu
authors.forename: G
authors.initials: G
authors.lastname: Chen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics*; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D009154:Mutation / Q000235:genetics*; D011788:Quality of Life
chemical_list: D066246:ErbB Receptors